CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed· 240 enrolled
Drug / intervention
Influsplit SSW® 2005/2006biological
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00372255
NCT00372255Phase 4Completed
CompareCT.gov

An Open, Phase IV Study on the Immunogenicity and Tolerability of Influsplit SSW® 2005/2006 in Children Aged 6 - 13 Years

GlaxoSmithKline·interventional·Posted Sep 6, 2006·Updated May 6, 2019

In Brief

A Phase 4 clinical trial evaluating Influsplit SSW® 2005/2006 for Influenza. Completed, enrolled 240 participants across 18 sites.

Detailed Summary

The study will evaluate the immune response and the tolerability of the influenza vaccine administered in children aged 6-13 years old.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsInfluenza
CountriesGermany
Collaborators--

Timeline

Phase 4CompletedFinished
2006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedSep 6, 2006
Enrollment StartNov 17, 2005
Primary CompletionMar 28, 2006
TodayJul 2, 2026
Enrollment to primary: 4 monthsPosted 19.8 years ago

Interventions

Influsplit SSW® 2005/2006biological

Study influenza vaccine was administered intramuscularly in the non-dominant arm